Adverse Effects of Clindamycin
Clindamycin's most significant adverse effect is Clostridioides difficile-associated colitis, which can be severe and potentially life-threatening, occurring in approximately 2-10% of patients taking this antibiotic. 1
Gastrointestinal Effects
Gastrointestinal side effects are the most common adverse reactions to clindamycin:
Pseudomembranous colitis: Reported in 1.9-2.5% of patients 2, 3
- Can be severe and potentially life-threatening
- Characterized by severe diarrhea, abdominal pain, fever
- Requires immediate discontinuation of the medication
Other GI effects 1:
- Abdominal pain (average duration: 4 days with 300 mg; 7 days with 600 mg) 4
- Nausea and vomiting
- Esophagitis and esophageal ulceration
- Unpleasant or metallic taste
Dermatologic Reactions
Skin reactions are the second most common category of adverse effects:
Maculopapular exanthema: Most frequently reported skin reaction 1, 5
- Can show preferential involvement of striae distensae 5
Severe skin reactions 1:
- Toxic Epidermal Necrolysis (some cases fatal)
- Acute Generalized Exanthematous Pustulosis (AGEP)
- Erythema multiforme
- Stevens-Johnson syndrome-like reactions
Other dermatologic effects 1:
- Pruritus
- Urticaria
- Angioedema
- Exfoliative dermatitis (rare)
Hypersensitivity Reactions
- Generalized mild to moderate morbilliform-like rashes
- Vesiculobullous rashes
- Anaphylactic shock (rare)
- Drug reaction with eosinophilia and systemic symptoms (DRESS)
Delayed-type hypersensitivity: Can be confirmed with patch testing 6
Other Systemic Effects
Hepatic effects 1:
- Jaundice
- Abnormal liver function tests
Renal effects 1:
- Acute kidney injury
Hematologic effects 1:
- Transient neutropenia (leukopenia)
- Eosinophilia
- Reports of agranulocytosis and thrombocytopenia
Musculoskeletal effects 1:
- Polyarthritis
Risk Factors for Adverse Effects
Several factors increase the risk of developing adverse effects:
- Higher doses: 600 mg dose associated with more frequent and severe side effects than 300 mg 4
- Older age: Increased incidence of diarrhea 3
- Parenteral administration: Higher risk of diarrhea compared to oral route 3
- Serious illness: Positive correlation with diarrhea development 2
- Abdominal or pelvic sepsis: Positive correlation with diarrhea development 2
- Total dose: Higher cumulative dose increases risk of diarrhea 2
Management of Adverse Effects
For mild GI symptoms: Symptomatic treatment may be sufficient
For severe diarrhea or suspected C. difficile colitis:
- Immediately discontinue clindamycin
- Provide fluid support
- Consider specific treatment for C. difficile if confirmed
For skin reactions:
- Discontinue medication for severe reactions
- Systemic corticosteroids may be needed for extensive rashes 5
Special Considerations
- Pregnancy: Category B - generally considered safe 7
- Nursing mothers: Use with caution; unknown if excreted in breast milk 7
- Pediatric use: Safety not established in children <12 years for topical preparations 7
- Drug interactions: